Pub Date : 2025-09-01Epub Date: 2025-09-09DOI: 10.1055/a-2554-4259
{"title":"Body Composition nach Tonsillektomie: Was bringen essenzielle Aminosäuren?","authors":"","doi":"10.1055/a-2554-4259","DOIUrl":"https://doi.org/10.1055/a-2554-4259","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":"104 9","pages":"547-548"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-02-24DOI: 10.1055/a-2368-7317
Ioana Brill, Stefan Michael Brill, Stefan Dazert, Christiane Völter, Thomas Stark
ADHEAR is a non-invasive, passive bone conduction hearing aid. It is a pressure-free device, which overcomes the skin problems and irritations of conventional devices. Patients with otosclerosis and stapes fixation with normal inner ear represent an audiological homogenous group. We tested the ADHEAR benefit for this group.Thirty-one patients with maximal conductive hearing loss were tested preoperatively with and without ADHEAR. Pure tone and speech recognition tests, Freiburger mono- and multisyllables, were performed. The performance was evaluated at four sound pressure levels (35, 50, 65, and 80 dB). Intraoperative findings confirmed otosclerosis in 28 cases.The free-field PTA4 (pure tone average at 500 Hz, 1, 2, 4 kHz) in patients with otosclerosis improved with ADHEAR by 8.1 (±7.14) dB. Multisyllable understanding without ADHEAR at 65 dB was 69.6%, and 87.3% with ADHEAR (p = 0.002). Monosyllable understanding without ADHEAR at 65 dB was 37.9%, and 61.2% with ADHEAR (p = 0.00008).ADHEAR in patients with otosclerosis improved their speech understanding significantly in most testsituations. Because of its size at the speech-relevant sound pressure levels of 50 and 65 dB, the gain is clinically relevant. In difficult and easy situations we observed ceiling and floor effects. Thus, ADHEAR appears to be at least temporarily a good rehabilitation alternative.
{"title":"[ADHEAR Performance in Cases with Maximal Conductive Hearing Loss in Otosclerosis].","authors":"Ioana Brill, Stefan Michael Brill, Stefan Dazert, Christiane Völter, Thomas Stark","doi":"10.1055/a-2368-7317","DOIUrl":"10.1055/a-2368-7317","url":null,"abstract":"<p><p>ADHEAR is a non-invasive, passive bone conduction hearing aid. It is a pressure-free device, which overcomes the skin problems and irritations of conventional devices. Patients with otosclerosis and stapes fixation with normal inner ear represent an audiological homogenous group. We tested the ADHEAR benefit for this group.Thirty-one patients with maximal conductive hearing loss were tested preoperatively with and without ADHEAR. Pure tone and speech recognition tests, Freiburger mono- and multisyllables, were performed. The performance was evaluated at four sound pressure levels (35, 50, 65, and 80 dB). Intraoperative findings confirmed otosclerosis in 28 cases.The free-field PTA4 (pure tone average at 500 Hz, 1, 2, 4 kHz) in patients with otosclerosis improved with ADHEAR by 8.1 (±7.14) dB. Multisyllable understanding without ADHEAR at 65 dB was 69.6%, and 87.3% with ADHEAR (p = 0.002). Monosyllable understanding without ADHEAR at 65 dB was 37.9%, and 61.2% with ADHEAR (p = 0.00008).ADHEAR in patients with otosclerosis improved their speech understanding significantly in most testsituations. Because of its size at the speech-relevant sound pressure levels of 50 and 65 dB, the gain is clinically relevant. In difficult and easy situations we observed ceiling and floor effects. Thus, ADHEAR appears to be at least temporarily a good rehabilitation alternative.</p>","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":" ","pages":"557-565"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143492624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-01-13DOI: 10.1055/a-2505-4691
Jiri Podzimek, Mihaly Peca, Martin Langmann
{"title":"[An unclear neck swelling in the corner of the jaw: a rare diagnosis for an ENT specialist].","authors":"Jiri Podzimek, Mihaly Peca, Martin Langmann","doi":"10.1055/a-2505-4691","DOIUrl":"10.1055/a-2505-4691","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":" ","pages":"572-574"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-09DOI: 10.1055/a-2655-8353
{"title":"Unverzichtbar für die Fort- und Weiterbildung.","authors":"","doi":"10.1055/a-2655-8353","DOIUrl":"https://doi.org/10.1055/a-2655-8353","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":"104 9","pages":"544-545"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-03-03DOI: 10.1055/a-2535-0366
Lilo Stroink, Florian Hoppe, Elisabeth Rehberg
Tracheostomy in children and adolescents is a rare procedure that differs from tracheostomy in adults in terms of indications, implementation and treatment challenges. This study is a unicentric retrospective analysis of the group of children and adolescents who were treated with a tracheostomy in the ENT Clinic at Hospital between 2007 and 2023. A total of 47 patients were treated with a tracheostomy. Anatomical changes in the airways and long-term ventilation were the most common indications. In 61.7 % of the children, the cannula was removed successfully during the course of treatment. In 38.3 % of cases, complications occurred during treatment, most commonly granulations. 3 children died during the observation period; none of the deaths was related to the tracheostomy. Despite the challenges, tracheostomy may offer an opportunity for seriously ill children and their families to bridge a difficult period of time and secure their airways.
{"title":"[Tracheotomy in children and adolescents - results from 15 years of clinical practice].","authors":"Lilo Stroink, Florian Hoppe, Elisabeth Rehberg","doi":"10.1055/a-2535-0366","DOIUrl":"10.1055/a-2535-0366","url":null,"abstract":"<p><p>Tracheostomy in children and adolescents is a rare procedure that differs from tracheostomy in adults in terms of indications, implementation and treatment challenges. This study is a unicentric retrospective analysis of the group of children and adolescents who were treated with a tracheostomy in the ENT Clinic at Hospital between 2007 and 2023. A total of 47 patients were treated with a tracheostomy. Anatomical changes in the airways and long-term ventilation were the most common indications. In 61.7 % of the children, the cannula was removed successfully during the course of treatment. In 38.3 % of cases, complications occurred during treatment, most commonly granulations. 3 children died during the observation period; none of the deaths was related to the tracheostomy. Despite the challenges, tracheostomy may offer an opportunity for seriously ill children and their families to bridge a difficult period of time and secure their airways.</p>","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":" ","pages":"566-571"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-09DOI: 10.1055/a-2346-8180
Achim Georg Beule, Rebecca Hasseli-Fräbel, Maximilian Ewertz, Fabian Paperlein, Maximilian Oberste, Claudia Rudack, Inga Nierkamp
In recent years, several biologics have been introduced into hospitals and clinics as alternatives to surgery and/or topical/oral cortisone therapy in patients with severe refractory chronic rhinosinusitis with polyps (CRSwNP). Advances in understanding the pathophysiology of CRSwNP in relation to the predominant type 2 endotype have also paved the way for understanding possible overlaps with hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA). In this article, we present the biologic treatment options currently approved in Germany for the treatment of severe CRSwNP - dupilumab, omalizumab and mepolizumab - together with guidance on practical management including side effects for the indication of CRSwNP. Tips on how to select the preferred agent for an individual patient to ensure safe, effective and cost-efficient treatment will be presented and awareness of HES and EGPA will be raised.
{"title":"[Biologicals in Type-2-Inflammation - from Chronic Rhinosinusitis with Nasal Polyps to Hypereosinophilic Syndrome].","authors":"Achim Georg Beule, Rebecca Hasseli-Fräbel, Maximilian Ewertz, Fabian Paperlein, Maximilian Oberste, Claudia Rudack, Inga Nierkamp","doi":"10.1055/a-2346-8180","DOIUrl":"https://doi.org/10.1055/a-2346-8180","url":null,"abstract":"<p><p>In recent years, several biologics have been introduced into hospitals and clinics as alternatives to surgery and/or topical/oral cortisone therapy in patients with severe refractory chronic rhinosinusitis with polyps (CRSwNP). Advances in understanding the pathophysiology of CRSwNP in relation to the predominant type 2 endotype have also paved the way for understanding possible overlaps with hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA). In this article, we present the biologic treatment options currently approved in Germany for the treatment of severe CRSwNP - dupilumab, omalizumab and mepolizumab - together with guidance on practical management including side effects for the indication of CRSwNP. Tips on how to select the preferred agent for an individual patient to ensure safe, effective and cost-efficient treatment will be presented and awareness of HES and EGPA will be raised.</p>","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":"104 9","pages":"579-600"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-09DOI: 10.1055/a-2552-5405
{"title":"Kommentar zu „Häusliches Monitoring nach Neurostimulationstherapie des N. hypoglossus“.","authors":"","doi":"10.1055/a-2552-5405","DOIUrl":"https://doi.org/10.1055/a-2552-5405","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":"104 9","pages":"546-547"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-09DOI: 10.1055/a-2554-4205
{"title":"Kommentar zu „Body Composition nach Tonsillektomie: Was bringen essenzielle Aminosäuren?“.","authors":"","doi":"10.1055/a-2554-4205","DOIUrl":"https://doi.org/10.1055/a-2554-4205","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":"104 9","pages":"548-549"},"PeriodicalIF":1.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号